Peripheral Blood Stem Cell TransplantationTransplantation, AutologousHematopoietic Stem Cell TransplantationHematopoietic Stem Cell MobilizationCyclophosphamideTransplantation ConditioningTransplantation, HomologousGranulocyte Colony-Stimulating FactorLeukapheresisMelphalanAntigens, CD34Blood Component RemovalHematologic NeoplasmsCombined Modality TherapyStem Cell TransplantationAntineoplastic Combined Chemotherapy ProtocolsMultiple MyelomaGraft vs Host DiseaseHematopoietic Stem CellsBusulfanMyeloablative AgonistsBone Marrow TransplantationGraft SurvivalTreatment OutcomeLymphoma, Non-HodgkinStem CellsAntineoplastic Agents, AlkylatingEtoposideThiotepaRemission InductionRecurrenceIfosfamideCarmustineVincristineCord Blood Stem Cell TransplantationCytophagocytosisSalvage TherapyHematopoiesisCytarabineDisease-Free SurvivalAmyloidosisTissue DonorsTransplantation ChimeraHodgkin DiseaseRetrospective StudiesSurvival RateWhole-Body IrradiationNeoplasmsDoxorubicinInfectionBlood Cell CountHistocompatibilitySurvival AnalysisTime FactorsBlood CellsPlatelet CountPOEMS SyndromeImmunosuppressive AgentsHistocompatibility TestingVidarabinePrednisoneLymphoma, T-CellCarboplatinTransplantation, IsogeneicBone Marrow PurgingLeukemia, Myeloid, AcuteLeukemiaRecombinant ProteinsDexamethasoneFollow-Up StudiesLymphomaFeasibility StudiesAntineoplastic AgentsCytomegalovirus InfectionsProspective StudiesGraft vs Leukemia EffectAnemia, AplasticImmunophenotypingFatal OutcomeBlood DonorsLeukocytes, MononuclearMyelodysplastic SyndromesBone MarrowLymphocyte DepletionLeukemia, Myelogenous, Chronic, BCR-ABL PositiveCell SeparationT-LymphocytesHematologic DiseasesHistiocytosis, Non-Langerhans-CellBreast NeoplasmsFlow CytometryEmbryonic Stem CellsBone Marrow DiseasesLeukocyte CountImmunomagnetic SeparationCyclosporineOpportunistic InfectionsPrecursor Cell Lymphoblastic Leukemia-LymphomaLivedo ReticularisImmunosuppression